Nigro G, Lionetti P, Digilio G, Multari G, Vania A, Midulla M. Viral infections in transfusion-dependent patients with α-thalassemia major: the predominant role of cytomegalovirus. Transfusion 1990;30:808-13.
Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124:318-22. Reviewed in Year Book of Infectious Diseases 1996: 167-8.
Nigro G, Krzysztofiak A, Castelli Gattinara G, Mango T, Mazzocco M, Porcaro MA, Provvedi S, Booth JC. Rapid progression of HIV disease in children with cytomegalovirus DNAemia. AIDS 1996;10:1127-33.
Nigro G, Krzysztofiak A, Bartmann U, Clerico A, Properzi E, Valia S, Castello M. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997;142:573-80.
Iannetti P, Nigro G, Spalice A, Faiella A, Boncinelli E. Cytomegalovirus infection and schizencephaly: Case reports. Ann Neurol 1998;43:123-7.
Nigro G, La Torre R, Anceschi MM, Mazzocco M, Cosmi EV. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am J Obstet Gynecol 1999;180:1222-6.
Nigro G, Mazzocco M, Anceschi MM, La Torre R, Antonelli G, Cosmi EV. Prenatal diagnosis of fetal cytomegalovirus infection following primary or recurrent maternal infection. Obstet Gynecol 1999;94:909-14.
Nigro G, Mazzocco M, Aragona C, D’Emilio C, Cosmi E. Hyperimmunoglobulin therapy for cytomegalovirus-associated infertility. Fertil Steril 2000;74:830-1.
Nigro G, Anceschi MM, Cosmi EV, Congenital Cytomegalic Disease Collaborating Group. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection, Brit J Obstet Gynaecol 2003;110:572-7
Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalic Disease Collaborating Group. Passive maternal immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62. Reply to letters. N Engl J Med 2005;353:2818-20. Recensito da: 1)Maloney JM, Sicherer SH, Pediatrics 2006;118:S54; 2) Obstetrical and Gynecological Survey 2006;61:155
La Torre R, Nigro G, Mazzocco M , Best AM, Adler SP. Placental enlargement in women with a primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006;43:994-1000. [IF 6.186]
Nigro G, Pietrobattista A, Divito S, Gambarara M. Oral ganciclovir therapy for immunocompetent infants with cytomegalovirus-associated hemorrhagic or intractable enterocolitis. J Pediatr Gastroenterol Nutr 2010;50:111-3. [IF 2.067]
Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, Shiboski S, Muci S, Anceschi M, Aziz N, Adler SP, Pereira L. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 2010:177:1298-1310.
Nigro G, Adler SP,Parruti G, Anceschi MM, Coclite E, Pezone I, Di Renzo GC. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy – a case-control study of the outcome in children. J Infect Dis 2012;205:215-27.
Nigro G, Capretti, Manganello AM, Best AM, Adler SP. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight. J Matern Fetal Neonatal Med 2015;28:168-71
Nigro G. Hyperimmune globulin in pregnancy for prevention of congenital cytomegalovirus disease. Expert Rev Anti Infect Ther 2017;15:977-86.
Nigro G, Adler SP. Congenital Cytomegalic Disease Collaborating Group. High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection. Clin Infect Dis 2020;71:1491-8
Nigro G. Hyperimmune globulin for congenital cytomegalovirus infection. N Engl J Med 2022;386;10:1002-3.
